Education
About Us
Working with TipRanks
Follow Us
CME Group (CME)
NASDAQ:CME
Earnings Data
Report Date
Apr 29, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
2.99Last Year’s EPS
2.8Same Quarter Last Year
Based on 8 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a strongly positive operational and financial picture — record volumes across multiple asset classes, double-digit growth in crypto activity, record market data revenue, continued revenue and adjusted earnings growth, and active capital returns. Management also outlined strategic investments (securities clearing, 24/7 crypto trading, event contracts) with clear near-term costs and guidance for higher operating spend. Key risks were primarily execution and regulatory: SEC approvals required for some cross-margining/treasury initiatives, legal uncertainty around certain prediction/sports contracts, cloud migration costs, and margin actions in volatile markets. On balance, the highlights (multiple record metrics, solid revenue/earnings growth, product expansion and capital returns) materially outweigh the contained lowlights and execution/regulatory risks.Company Guidance
Record Volume and Broad-Based Growth
Average daily volume (ADV) in 2025 increased 6% to 28.1 million contracts, marking the fifth consecutive year of record volume with all-time records in interest rate, energy, metals, agricultural, and crypto complexes. International ADV averaged 8.4 million contracts per day, up 8% year-over-year.
Strong Revenue and Earnings Performance
Full-year 2025 revenue of $6.5 billion grew 6% versus 2024; adjusted net income was $4.1 billion, driving 9% adjusted EPS growth for the year. Q4 revenue was $1.65 billion, up 8% year-over-year, with Q4 adjusted net income of $1.0 billion ($2.77 per share), up 10% from Q4 2024.
High and Improving Profitability
Adjusted operating margin for 2025 was 69.4%, an improvement of 110 basis points versus 2024. Q4 adjusted operating margin was 67% with adjusted operating income of approximately $1.1 billion.
Market Data Momentum
Market data revenue surpassed $800 million for the first time in 2025 (up 13% year-over-year), with Q4 market data revenue up 15% to $208 million. Management attributes growth drivers as ~50% new user expansion, ~25% product innovation, and ~25% pricing integrity.
Crypto and Retail Product Strength
Crypto ADV in Q4 averaged 379,000 contracts, up 92% year-over-year, representing over $13 billion in notional value traded per day. Retail-focused micro products were up 59% in Q4 to a record 4.4 million contracts per day. Over 68 million event contracts traded within six weeks of launch, including 7 million markets-related contracts.
Capital Deployment and Liquidity
Cash totaled approximately $4.6 billion at quarter end (including $1.3 billion Austria proceeds). The company repurchased $256 million of shares in Q4 and an additional $276 million early in 2026, and paid $455 million in dividends in Q4 (about $3.9 billion for 2025). Austria proceeds earmarked for repurchases over time.
Product & Strategic Milestones
December approval from the SEC for CME Securities Clearing with planned launch later in the year; expansion of event contracts and planned 24/7 trading for the crypto suite next quarter; new crypto futures (Cardano, Chainlink, Stellar) launching Feb 9; planned 100-ounce silver contract next week.
Guidance and Fee Actions
Transaction fee and market data pricing changes are expected to increase total revenue by approximately 1.0%–1.5% on comparable activity. 2026 guidance: adjusted operating expenses excluding license fees ~ $1.695 billion, capital expenditures ~ $85 million, adjusted effective tax rate 23.5%–24.5%.
CME Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CME Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 04, 2026 | $293.07 | $294.62 | +0.53% |
Oct 22, 2025 | $267.38 | $266.58 | -0.30% |
Jul 24, 2025 | $273.90 | $274.59 | +0.25% |
Apr 23, 2025 | $261.88 | $257.86 | -1.54% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does CME Group (CME) report earnings?
CME Group (CME) is schdueled to report earning on Apr 29, 2026, Before Open (Confirmed).
What is CME Group (CME) earnings time?
CME Group (CME) earnings time is at Apr 29, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CME EPS forecast?
CME EPS forecast for the fiscal quarter 2026 (Q1) is 2.99.